Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fasting Condition

NCT02185833 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: DIRITHROMYCIN 500 MG ENTERIC COATED TABLET
DRUG: DYNABAC 250 MG ENTERIC COATED TABLET

Sponsor

Pharmaceutical Research Unit, Jordan

Collaborators

[object Object]